Lipoprotein changes and increased affinity of LDL for their receptors after acipimox treatment in hypertriglyceridemia
- 1 February 1990
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 81 (1) , 41-49
- https://doi.org/10.1016/0021-9150(90)90057-p
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Plasma lipid lowering activity of acipimox in patients with type II and type IV hyperlipoproteinemiaAtherosclerosis, 1988
- Abnormal regulation of LDL receptor activity and abnormal cellular metabolism of hypertriglyceridaemic low density lipoprotein: normalization with bezafibrate therapyEuropean Journal of Clinical Investigation, 1987
- Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacinJournal of the American College of Cardiology, 1986
- Defective metabolism of hypertriglyceridemic low density lipoprotein in cultured human skin fibroblasts. Normalization with bezafibrate therapy.Journal of Clinical Investigation, 1985
- Cholesterol net transport, esterification, and transfer in human hyperlipidemic plasma.Journal of Clinical Investigation, 1983
- Regulation of the activity of the low density lipoprotein receptor in human fibroblastsCell, 1975
- The metabolism of very low density lipoprotein proteins I. Preliminary in vitro and in vivo observationsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1972
- Induction of adipose tissue lipoprotein lipase by nicotinic acidBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1968
- Efficient Trace-labelling of Proteins with IodineNature, 1958
- THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUMJournal of Clinical Investigation, 1955